Invention Grant
US09445762B2 Fully self-contained unit dose devices for allergy skin testing
有权
用于过敏皮肤测试的完全独立的单位剂量装置
- Patent Title: Fully self-contained unit dose devices for allergy skin testing
- Patent Title (中): 用于过敏皮肤测试的完全独立的单位剂量装置
-
Application No.: US14012821Application Date: 2013-08-28
-
Publication No.: US09445762B2Publication Date: 2016-09-20
- Inventor: Timothy R Sullivan , Jeff Gjertsen , Jesse Hancock
- Applicant: Mystic Pharmaceuticals, Inc.
- Applicant Address: US TX Austin
- Assignee: Mystic Pharmaceuticals, Inc.
- Current Assignee: Mystic Pharmaceuticals, Inc.
- Current Assignee Address: US TX Austin
- Main IPC: A61B5/00
- IPC: A61B5/00

Abstract:
The present invention discloses a system for applying antigens or other diagnostic substances to the skin of a subject for allergy testing. The system is comprised of fully contained predetermined quantities of antigenic or other testing material contained in sealed unit doses that maintain sterility and provide for precise handling and administration. Each unit dose contains an internal mechanism. The mechanism provides for piercing the laminate and comprises an internal channel for fluid communication, and may have an abrasive protrusions at the tip for piercing or abrading the skin surface to aid in generating a diagnostic response. The unit dose or doses may be housed in devices that provide for administration of the test material to the subject wherein the applicator section may contain protrusions for piercing or abrading the skin of a subject.
Public/Granted literature
- US20150126898A1 Fully Self-Contained Unit Dose Devices for Allergy Skin Testing Public/Granted day:2015-05-07
Information query